Enzyvant, a subsidiary of Sumitovant Biopharma, develops regenerative therapeutics for rare diseases such as congenital athymia. The Cary location is their headquarters.
2000 CentreGreen Way, Suite 350
Employment range in NC
Primary site activity
All company activities
Potential end market(s)
Products under development
Investigational RVT-802, a one-time regenerative therapy, is cultured human thymus tissue engineered to generate a functioning immune response in pediatric patients with congenital athymia.